PLC beta 4-independent Ca2+ rise via muscarinic receptors in the mouse suprachiasmatic nucleus.
Cholinergic regulation of the suprachiasmatic nucleus (SCN) has been extensively studied although the intracellular signaling mechanisms are not well understood. We examined immunostaining for phospholipase C-beta (PLC-beta) families that couple to muscarinic acetylcholine receptors (mAChR) and demonstrated the expression of PLC-beta 1 and beta 4 in the mouse SCN. Ca2+ imaging analysis indicated that the MI-mAChR antagonist, pirenzepine blocked carbachol-induced Ca2+ elevation in the SCN and the response was equivalent between the wild type and the PLC-beta 4-knockout mice. In addition, the knockout mice displayed locomotor and temperature rhythms coupling to 24 h light/dark cycles. Therefore, it was proposed that PLC-beta 1 but not PLC-beta 4 was involved in the mAChR-mediated Ca2+ signaling in the SCN.
Ikeda
M
M
Advanced Research Center for Human Sciences, School of Human Sciences, Waseda University, Saitama, Japan.
Sugiyama
T
T
Suzuki
K
K
Moriya
T
T
Shibata
S
S
Katsuki
M
M
Allen
C N
CN
Yoshioka
T
T
D000818:Animals; D002118:Calcium / Q000378:metabolism*; D002217:Carbachol / Q000494:pharmacology; D002799:Cholinergic Fibers / Q000378:metabolism; D002940:Circadian Rhythm / Q000502:physiology; D007150:Immunohistochemistry; D007527:Isoenzymes / Q000378:metabolism*; D051379:Mice; D018345:Mice, Knockout; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000378:metabolism / Q000502:physiology; D054799:Phospholipase C beta; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology*; D013493:Suprachiasmatic Nucleus / Q000378:metabolism* / Q000502:physiology*; D010738:Type C Phospholipases / Q000378:metabolism*
D007527:Isoenzymes; D011976:Receptors, Muscarinic; D002217:Carbachol; D010738:Type C Phospholipases; D054799:Phospholipase C beta; C518043:Plcb4 protein, mouse; D002118:Calcium